The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
Several years ago, amateur athlete Hemi Re’em was shocked to discover that his coronary arteries were 90 percent blocked despite his seemingly good health. This set him on a path to cofounding Yopi Technologies. Yopi (Your Online Personal Instructor) is a first-of-its-kind, AI-based wearable device that monitors oxygen consumption through electrolytes in the sweat. The goal is to detect heart deterioration and measure overall wellness.
Multiple myeloma is the second most common cancer that impacts blood cells. It primarily affects people in their mid-60s or older. Over time, patients become resistant to current treatment drugs that are initially effective. That’s why UB-Therapeutics, a company founded and run by Technion alumni and faculty, is working on a new drug. Existing drugs target proteasomes, which maintain cellular function. The new drug aims to inhibit proteasome activity in cancer cells by binding to ubiquitin, a small regulatory protein found in most tissues. “By leveraging the cell’s own natural processes, we aim to develop a more selective and effective…
ArtiFascia®, a patch-like dural repair graft, recently obtained approval from the U.S. Food and Drug Administration. The device – developed by Nurami Medical, a startup in Haifa co-founded by Technion alumna Nora Nseir Manassa – will revolutionize neurosurgery. Dura mater is the outermost layer of the membrane that surrounds the brain and spinal cord, protecting the central nervous system from physical damage. The resorbable device, made of electrospun nanofibers, promotes tissue regeneration of the dura mater while also preventing cerebrospinal fluid (CSF) leaks and bacterial penetration sometimes caused by suture holes during surgery. “The necessity to cover the brain with…
Chronic kidney disease (CKD) affects an estimated 10% of the world, which is just under 800 million people. According to the US-based National Kidney Foundation, 90% of people affected by the disease don’t know they have it at the early stages, allowing it to progress undetected. In some cases, CKD is caught only at “end stage,” when kidneys are failing and require either a transplant or dialysis — a grueling, weekly procedure to remove waste and excess fluid from the blood. The average survival rate of dialysis patients is five years. Curespec, based in Yehud-Monosson in Israel, claims its unique device, Nephrospec,…
A unique “coworking space” for farmers in drought-stricken Rwanda will soon offer local growers a sustainable way to produce crops. Agriculture accounts for a third of landlocked Rwanda’s GDP but relies on rainfall and suffers low levels of productivity. The unique site, including its purpose-built water source and an energy network, was designed by Israeli precision irrigation pioneer Netafim and built in cooperation with the government, which provided $50 million in funding.
“When we say agriculture, we think green and plants and land, it sounds very sexy. But the reality is that agriculture is one of the major contaminants in the world, both in terms of groundwater contamination and greenhouse gas emissions,” says Rafi Levi. “And fertilizers are the No. 1 contaminant in agriculture.” Levi is the CEO and cofounder of DOTS (Data of the Soil), an Israeli startup bent on helping farmers cut down on the use of excess fertilizers by providing them with real-time monitoring of fertilizer in the soil. This can save them a lot of money and, of course, protect…
An Israeli company that develops medical treatments using helpful bacteria to fight disease is expanding the clinical trial for its drug to battle cancer. The biopharma startup recently opened a second site for its ongoing clinical trial at Beilinson Hospital in Petah Tikva, near Tel Aviv. The first site is located at Rambam Health Care Campus in Haifa, northern Israel. Biomica identifies and selects microbes to treat specific diseases that will enhance how the body’s immune system responds. Biomica is a biopharmaceutical startup working to create microbiome-based therapeutics to treat immune-mediated and infectious diseases. The company’s Co-founder and CSO Yehuda Ringel…
Eliad Peretz ’13 was just 10 years old when he decided what he wanted to do in life. Helping his grandfather harvest olives, the pair would return at dusk, “lay back on blankets on the lawn, and look up at the sky,” Dr. Peretz recalled. “Those were the moments that helped me identify my path.” By fifth grade, he wrote what he called his first five-year plan, already knowing he wanted to work at the National Aeronautics and Space Administration (NASA). Earlier this year, the NASA scientist and Technion alumnus was awarded the NASA Exceptional Achievement Medal — entering the…
The rate of childhood peanut allergies from birth to 18 years old is three to four times higher compared to 20 years ago. Those with a severe allergy can be sent into anaphylaxis just by smelling the legume. This can be especially problematic for those with allergies in Israel, as the country does not have standardized regulations that require uniform labeling of allergens on food packaging. But Technion alumna Dr. Mona Kidon may have a solution to this issue. She has created an immunotherapy that permits young peanut allergy sufferers to build up immunity to peanuts until they can ultimately…
“Nearly all dwellings and buildings require heating and cooling, now more than ever in the face of climate change,” says ThermoTerra. “The increasing use of air conditioners transfers heat from the inside to the outside of buildings, and this in addition to the CO2 emissions resulting from air conditioning energy use only exacerbates the problem.” To address this, the company has developed a cooling and heating technology that avoids CO2 emissions and heating the environment and uses carbon capture materials. Its pilot structure at Ben-Gurion University demonstrated passive cooling continuously to 24°C (75F) solely using water collected from the relatively…
Gal Frenkel built a wooden deck and pool in the backyard of his home in central Israel the summer after he had sold luxury wedding/bar mitzvah event planner Sky Productions (opening price for an event: $1 million). Frenkel hosted a few parties there, and after the summer he didn’t think much about his pool and deck. When he went out to look at it the following spring, he was shocked. “The whole area looked old and ruined and faded. I was so disappointed,” he tells ISRAEL21c. “I called the guy who installed the deck and said, ‘Nadav, you really messed it up.’…
Common pedagogical wisdom states that the younger a child begins learning a new language, the easier it is for them to acquire. And adhering to that philosophy, Israeli startup Curiosity Robotics has created a friendly, chatty little robot to teach English as a foreign language to preschoolers. Meet Aico, the charming, smiling artificial intelligence teaching tool that is the product of three years of research at Tel Aviv University’s Curiosity Labs. Aico is programmed to use a teaching method devised by British-Israeli educator Helen Doron, which advocates for children starting to learn a second language as early as three months of age. Curiosity Robotics is a…